403 related articles for article (PubMed ID: 33253686)
1. Chronic Liver Diseases and the Microbiome-Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease.
Acharya C; Bajaj JS
Gastroenterology; 2021 Jan; 160(2):556-572. PubMed ID: 33253686
[TBL] [Abstract][Full Text] [Related]
2. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
[TBL] [Abstract][Full Text] [Related]
3. [The gut microbiome is important in chronic liver disease].
Christensen E
Ugeskr Laeger; 2019 Jan; 181(2):. PubMed ID: 30618372
[TBL] [Abstract][Full Text] [Related]
4. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
[TBL] [Abstract][Full Text] [Related]
5. The role of gut microbiota in intestinal and liver diseases.
Hrncir T; Hrncirova L; Kverka M; Tlaskalova-Hogenova H
Lab Anim; 2019 Jun; 53(3):271-280. PubMed ID: 30580671
[TBL] [Abstract][Full Text] [Related]
6. Intestinal microbiota in liver disease.
Haque TR; Barritt AS
Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):133-42. PubMed ID: 27048904
[TBL] [Abstract][Full Text] [Related]
7. Microbiome: Emerging Concepts in Patients with Chronic Liver Disease.
Reuter B; Bajaj JS
Clin Liver Dis; 2020 Aug; 24(3):493-520. PubMed ID: 32620285
[TBL] [Abstract][Full Text] [Related]
8. [Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation].
Aitbaev KA; Murkamilov IT; Fomin VV
Ter Arkh; 2017; 89(8):120-128. PubMed ID: 28914862
[TBL] [Abstract][Full Text] [Related]
9. The relevance of intestinal dysbiosis in liver transplant candidates.
Grąt M; Hołówko W; Wronka KM; Grąt K; Lewandowski Z; Kosińska I; Krasnodębski M; Wasilewicz M; Gałęcka M; Szachta P; Zborowska H; Patkowski W; Krawczyk M
Transpl Infect Dis; 2015 Apr; 17(2):174-84. PubMed ID: 25728703
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota Targeted Approach in the Management of Chronic Liver Diseases.
Liu J; Yang D; Wang X; Asare PT; Zhang Q; Na L; Shao L
Front Cell Infect Microbiol; 2022; 12():774335. PubMed ID: 35444959
[TBL] [Abstract][Full Text] [Related]
11. Fecal Microbiota Transplantation for Chronic Liver Diseases: Current Understanding and Future Direction.
Lechner S; Yee M; Limketkai BN; Pham EA
Dig Dis Sci; 2020 Mar; 65(3):897-905. PubMed ID: 32020359
[TBL] [Abstract][Full Text] [Related]
12. Alterations in gut microbial function following liver transplant.
Bajaj JS; Kakiyama G; Cox IJ; Nittono H; Takei H; White M; Fagan A; Gavis EA; Heuman DM; Gilles HC; Hylemon P; Taylor-Robinson SD; Legido-Quigley C; Kim M; Xu J; Williams R; Sikaroodi M; Pandak WM; Gillevet PM
Liver Transpl; 2018 Jun; 24(6):752-761. PubMed ID: 29500907
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial proteins: intestinal guards to protect against liver disease.
Hendrikx T; Schnabl B
J Gastroenterol; 2019 Mar; 54(3):209-217. PubMed ID: 30392013
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiome and liver disease.
Betrapally NS; Gillevet PM; Bajaj JS
Transl Res; 2017 Jan; 179():49-59. PubMed ID: 27477080
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota changes and chronic hepatitis C virus infection.
Preveden T; Scarpellini E; Milić N; Luzza F; Abenavoli L
Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):813-819. PubMed ID: 28621554
[TBL] [Abstract][Full Text] [Related]
16. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota and Complications of Liver Disease.
Acharya C; Bajaj JS
Gastroenterol Clin North Am; 2017 Mar; 46(1):155-169. PubMed ID: 28164848
[TBL] [Abstract][Full Text] [Related]
18. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans.
Maccioni L; Gao B; Leclercq S; Pirlot B; Horsmans Y; De Timary P; Leclercq I; Fouts D; Schnabl B; Stärkel P
Gut Microbes; 2020 Nov; 12(1):1782157. PubMed ID: 32588725
[TBL] [Abstract][Full Text] [Related]
19. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis.
Ye JZ; Li YT; Wu WR; Shi D; Fang DQ; Yang LY; Bian XY; Wu JJ; Wang Q; Jiang XW; Peng CG; Ye WC; Xia PC; Li LJ
World J Gastroenterol; 2018 Jun; 24(23):2468-2481. PubMed ID: 29930468
[TBL] [Abstract][Full Text] [Related]
20. A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature.
Giuffrè M; Campigotto M; Campisciano G; Comar M; Crocè LS
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G889-G906. PubMed ID: 32146836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
